Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2019 Q2- Text added to 2019 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
add, arm, BLA, conclusion, Curie, Department, expertise, failure, family, FDS, GlaxoSmithKline, grace, GSK, immunomodulatory, institutional, intention, judgment, letter, LLP, Marie, negotiating, notice, November, Pharm, Pierre, proof, protocol, qualify, Savient, site, timeline, trailing, trivalent, UPMC, validation, written
Removed:
aggressive, Amortization, amortizing, cohort, equipment, licensing
Valuein 2019 Q2 filing- Value in 2019 Q3 filing
Original filings
Filing view